|
HIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.52589999999897E-05 |
| Normal-vs-Stage3 |
6.13419981476682E-10 |
| Normal-vs-Stage4 |
1.74450000001158E-07 |
| Stage1-vs-Stage2 |
9.636800E-01 |
| Stage1-vs-Stage3 |
5.159800E-02 |
| Stage1-vs-Stage4 |
9.169600E-01 |
| Stage2-vs-Stage3 |
2.778000E-01 |
| Stage2-vs-Stage4 |
9.097600E-01 |
| Stage3-vs-Stage4 |
1.495600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.380160E-04 |
| Normal-vs-Asian |
4.76530000015352E-07 |
| Caucasian-vs-AfricanAmerican |
9.965600E-02 |
| Caucasian-vs-Asian |
3.643900E-02 |
| AfricanAmerican-vs-Asian |
9.768400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1529444893531E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
4.566000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62581059726108E-12 |
| Normal-vs-Age(61-80Yrs) |
1.09510001067292E-09 |
| Normal-vs-Age(81-100Yrs) |
1.197600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.015200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.596200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.625000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.551780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.868800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.090400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.447700E-02 |
| Classical-VS-Follicular |
6.325900E-02 |
| Classical-VS-Other |
2.291800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
9.800000E-01 |
| Tall-VS-Other |
4.299400E-01 |
| Tall-VS-Normal |
1.32610000003197E-06 |
| Follicular-VS-Other |
6.051400E-01 |
| Follicular-VS-Normal |
4.88239999985041E-07 |
| Other-VS-Normal |
1.336570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4432899320127E-15 |
| Normal-vs-N1 |
1.05480000001101E-06 |
| N0-vs-N1 |
6.022600E-01 |
|
|
